31 January 2020
We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Mr Tim Briggs at Spire include:
Rezum, Robotic radical prostatectomy; Radical cystoprostatectomy; Diagnosis and treatment of prostate cancer; Diagnosis and treatment of bladder cancer; Benign prostate disease; UroLift surgery for benign prostate enlargement; PSA assessment; Haematuria; testicular and scrotal conditions; hydroceles, epididymal cysts, vasectomy, urinary incontinence; Urodynamics; female incontinence; recurrent urinary tract infections.
I am a Consultant Urological Surgeon at University College London Hospital NHS Trust. I qualified from St Bartholomew's Medical School in 1984. I spent a year in the Concord Hospital in Sydney Australia. As a consultant, I have developed an interest in prostate cancer and have used the Da Vinci Robotic System from 2010. In 2012 I became part of the pelvic cancer team at University College London Hospital where I routinely perform robotic radical prostatectomies for the treatment of prostate cancer.
Robotic surgery involves minimal access surgery so patients don’t have large scars and the recovery time is quicker which means they are usually home within 1-2 days after major surgery. With patients undergoing robotic radical prostatectomy for prostate cancer the type of operation they have will depend very much on the stage and grade of cancer, but all these aspects are discussed in great detail with my patients so that they have a full understanding of what their surgery will involve prior to undergoing surgery.
I am also involved with the surgical school at UCH. This explains to patients the nuances and side effects of the operation in a group session so they are able to make informed decisions on their treatment. I have instigated the surgical planning sheet, that is now routinely used at UCH, to plan every case that is performed using MRI and biopsy results.
I am one of the few surgeons involved in the NeuroSAFE study and offer frozen sections during nerve sparing robotic prostatectomy to try and preserve erectile function for as many patients as is possible, without compromising the oncological outcomes.
Currently, I have performed over 200 laparoscopic radical prostatectomies and in excess of over 1000 robotic radical prostatectomies.
In my private practice, as well as performing robotic radical prostatectomies, I investigate, diagnose and treat patients with prostate and bladder cancer and perform transperineal prostate biopsies following multi-modality MRI in the diagnosis of prostate cancer. I also treat benign prostate disease and perform benign prostate surgery/UroLift and scrotal/genital surgery. I also see patients with general urological conditions such as haematuria (blood in the urine), urinary tract infections, and female incontinence. I like to take time to explain sensitive problems in plain English. Not all urology problems require surgery so I explain all the different treatment options with my patients - helping them to come to the correct treatment choice that is right for them, in their own time.
In this day of super-specialisation, in the unlikely event I felt a problem lied outside the scope of my practice, I would recommend a colleague who I thought would be more appropriate for that particular urological condition. At Spire Bushey, I also chair the Multi-Disciplinary Team meeting in which all urological patients diagnosis and treatment options are discussed and this ensures the quality of all cancer management plans.
General Medical Council Number: C2932600Back to top
British Association of Urological Surgeons
British Association of Urological Surgeons Oncology Group
European Association of Urology
European Robotic Urological Symposium Group
Consultant Urologist, University College Hospital (UCH)
In my spare time I am a keen cyclist.
21 October 2019
Read our latest Q and A with ENT Consultant, Mr Jonathn Hughes on head and neck cancer.